Furthermore, increased AKT3 mRNA levels were associated with increased patient survival and lower grade glioblastomas suggesting a more favourable outcome for these patients, whereas AKT1 and AKT2 expression was increased in higher grade tumours [72]. The gene discussed is AKT1; the disease is neoplasm.